Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability First Quarter 2024 Insurance Revenue growth of 8% year-over-year First Quarter 2024 GAAP Net Loss from Continuing Operations of $23.2 million versus First Quarter 2023 loss of$79.7 million First Quarter Adjusted EBITDA profitability of $6.8 million versus prior period loss of$37.5 million Improves 2024 guidance to Insurance Revenue of $1.30 billion -$1.35 billion and ...